Table 4.
Major adverse events | |
Death | 0 (0) |
Cardiovascular collapse requiring advanced cardiac life support | 0 (0) |
Seizure | 0 (0) |
Pneumothorax | 0 (0) |
Minor adverse eventsa | |
Respiratory compromise | |
New oxygen saturation <85% | 7 (4) |
Oxygen saturation decrease by >10%b | 8 (4) |
In-flight change in ventilator settingsc | 4 (2) |
Cardiovascular compromise | |
New mean arterial pressure <60 mm Hg | 5 (3) |
New heart rate <60 beats per minute | 4 (2) |
New arrhythmia | 3 (2) |
New administration of medicine for compromise of vital signsd | 17 (9) |
Administration of sedation/paralysis for vital sign change or ventilator dysynchrony | 15 (8) |
Values are presented as number (percentage). aFor 180 patients with complete physiologic data during flight. bIf normoxemic, oxygen saturation of greater than 90% before flight. cVentilator interventions included switching to manual ventilation or beginning inhaled prostacyclin. dIncludes new administration of fluid bolus, beta blockers, or titration of vasopressors.